GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Antares Pharma, Inc. (ATRS) [hlAlert]

Rating:
Buy ATRS
up 69.15 %

Antares Pharma, Inc. (ATRS) rated Buy with price target $5.75 by Ladenburg Thalmann

Posted on: Thursday,  Aug 8, 2013  10:25 AM ET by Ladenburg Thalmann

Ladenburg Thalmann rated Buy Antares Pharma, Inc. (NASDAQ: ATRS) on 08/08/2013. Previously Ladenburg Thalmann rated Buy Antares Pharma, Inc. (NASDAQ: ATRS) on
06/29/2009., when the stock price was $1.07. Since then, Antares Pharma, Inc. has gained 69.16% as of 01/25/2016's recent price of $1.81.
If you would have followed the previous Ladenburg Thalmann's recommendation on ATRS, you would have gained 69.15% of your investment in 2401 days.

Antares Pharma, Inc. (Antares) is a product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating (Easy Tec) tablets. Two of these platforms have generated United States Food and Drug Administration (FDA) approved products. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company has operating facilities in the United States and Switzerland. Its United States operation manufactures and markets reusable needle-free injection devices and related disposables, and develops disposable pressure assisted auto injector and pen injector systems.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/8/2013 10:25 AM Buy
None
4.64 5.75
as of 12/13/2013
1 Week down  -0.50 %
1 Month up  5.89 %
3 Months down  -9.81 %
1 YTD up  3.67 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/13/2009 4:25 PM Buy
None
0.99 3.00
6/29/2009 4:25 PM Buy
None
1.07 2.40

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy